Renaissance Technologies’s Salarius Pharmaceuticals SLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-235
Closed -$15K 3921
2024
Q1
$15K Buy
235
+15
+7% +$957 ﹤0.01% 3611
2023
Q4
$17K Buy
220
+19
+9% +$1.47K ﹤0.01% 3598
2023
Q3
$16K Buy
201
+30
+18% +$2.39K ﹤0.01% 3548
2023
Q2
$31K Buy
171
+4
+2% +$725 ﹤0.01% 3697
2023
Q1
$38K Buy
167
+31
+23% +$7.05K ﹤0.01% 3716
2022
Q4
$25K Sell
136
-75
-36% -$13.8K ﹤0.01% 3927
2022
Q3
$124K Buy
211
+32
+18% +$18.8K ﹤0.01% 3521
2022
Q2
$113K Buy
179
+158
+752% +$99.7K ﹤0.01% 3816
2022
Q1
$25K Sell
21
-39
-65% -$46.4K ﹤0.01% 3991
2021
Q4
$89K Buy
+60
New +$89K ﹤0.01% 3702
2021
Q2
Sell
-79
Closed -$352K 3751
2021
Q1
$352K Buy
+79
New +$352K ﹤0.01% 3015
2020
Q2
Sell
-76
Closed -$155K 3738
2020
Q1
$155K Buy
76
+56
+280% +$114K ﹤0.01% 3149
2019
Q4
$222K Buy
20
+1
+5% +$11.1K ﹤0.01% 3167
2019
Q3
$306K Hold
19
﹤0.01% 3032
2019
Q2
$769K Buy
19
+1
+6% +$40.5K ﹤0.01% 2816
2019
Q1
$532K Buy
18
+4
+29% +$118K ﹤0.01% 2903
2018
Q4
$339K Buy
14
+5
+56% +$121K ﹤0.01% 2992
2018
Q3
$331K Buy
9
+6
+200% +$221K ﹤0.01% 2986
2018
Q2
$223K Buy
3
+1
+50% +$74.3K ﹤0.01% 3053
2018
Q1
$643K Buy
2
+1
+100% +$322K ﹤0.01% 2825
2017
Q4
$314K Hold
1
﹤0.01% 3014
2017
Q3
$183K Buy
+1
New +$183K ﹤0.01% 3013
2017
Q2
Hold
0
3068
2016
Q4
Hold
0
-$266K 3426
2016
Q3
Hold
0
-$147K 2993
2016
Q2
Hold
0
3106